Centene Swings to Loss on Writedown

06:49am, Wednesday, 29'th Oct 2025
Centene swung to a third-quarter loss as enrollees in Affordable Care Act plans sought out more costly medical care, the latest evidence of health insurers' struggles to regain their former profitabil
Centene's health benefits ratio increases to 92.7% in the quarter from 89.2% in the same period last year.
Centene on Wednesday reported a surprise profit for the third quarter, helped by a low tax rate.
-- GAAP Diluted Loss Per Share of $(13.50); Adjusted Diluted Earnings Per Share of $0.50 -- Adjusted diluted EPS of $0.50 in the third quarter of 2025, including a $0.10 benefit of a low adjusted effe

Artisan Partners Q3 2025 Position Updates

02:20am, Tuesday, 28'th Oct 2025
Shares of Centene plunged after the company withdrew its 2025 guidance, driven by higher-than-expected market acuity on the ACA marketplaces and elevated Medicaid cost trends. Align Technology is a me
CNC braces for Q3 results as revenue growth may be offset by rising medical costs and shrinking Medicaid memberships.
We aim to hold both high quality mid cap companies trading at bargains and deeply discounted businesses with a self-help catalyst. D.R. Horton's self-help strategy reduced the capital commitment to th
We purchased several new fund holdings across various sectors. Sempra has been shifting its strategic focus from its highly regulated California operations to its growing presence in Texas. Regeneron
U.S. healthcare insurance providers Centene Corporation (NYSE:CNC) and Oscar Health Inc. (NYSE:OSCR) stock are trading lower as their peer Molina Healthcare Inc. (NYSE:MOH) reported disappointing annu

Centene: Like ELV, Use The Panic To Buy And Forget

11:10am, Wednesday, 22'nd Oct 2025
Centene was hit harder than UnitedHealth Group or Elevance Health, as they turned unprofitable, losing $253 million last quarter. The company's strong financial track record and long-term goals convin

Centene: High-Risk Buy With Huge Potential

01:34pm, Tuesday, 21'st Oct 2025
Centene Corporation faces high costs and near-term profitability challenges, but offers significant long-term upside if margins recover. CNC's Q3 earnings are expected to be volatile, with revenue lik

Centene: Strong Buy, For All The Wrong Reasons

04:38am, Tuesday, 21'st Oct 2025
Centene moat shows cracks, yet valuation implies a full collapse. CNC's scale remains an asset, though it no longer guarantees stability. Efficiency gains have peaked, leaving limited room for.
Medicare Advantage plans will be available to more than 51 million beneficiaries in 32 states; Prescription Drug Plans will continue to be offered nationwide New in 2026: Wellcare to transition Medica
Graphene Investments SAS fully exited its position in Centene Corporation (CNC 0.48%) during the third quarter, selling approximately 55,600 shares in a transaction estimated at ~$3.02 million as of O
RALEIGH, N.C. , Oct. 8, 2025 /PRNewswire/ -- WellCare of North Carolina (WellCare), an NC Medicaid health plan and subsidiary of Centene Corporation (NYSE: CNC), is supporting health-related resourc
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE